Home/Filings/4/0001209191-20-051505
4//SEC Filing

Polaris Management Co. VII, L.L.C. 4

Accession 0001209191-20-051505

CIK 0001634379other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 5:12 PM ET

Size

36.9 KB

Accession

0001209191-20-051505

Insider Transaction Report

Form 4
Period: 2020-09-18
Transactions
  • Conversion

    Common Stock

    2020-09-18+1,832,5822,047,544 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+15,118178,942 total(indirect: See footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-181,832,5820 total(indirect: See footnote)
    Common Stock (1,832,582 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-18128,2010 total(indirect: See footnote)
    Common Stock (128,201 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-09-18451,6660 total(indirect: See footnote)
    Common Stock (451,666 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-09-1815,1180 total(indirect: See footnote)
    Common Stock (15,118 underlying)
  • Conversion

    Common Stock

    2020-09-18+451,6662,499,210 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+128,201143,239 total(indirect: See footnote)
  • Purchase

    Common Stock

    2020-09-18$13.00/sh+214,962$2,794,506214,962 total(indirect: See footnote)
  • Purchase

    Common Stock

    2020-09-18$13.00/sh+15,038$195,49415,038 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+20,585163,824 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+216,1062,715,316 total(indirect: See footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2020-09-1820,5850 total(indirect: See footnote)
    Common Stock (20,585 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-09-18216,1060 total(indirect: See footnote)
    Common Stock (216,106 underlying)
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2020-09-18451,6660 total(indirect: See footnote)
    Common Stock (451,666 underlying)
  • Conversion

    Common Stock

    2020-09-18+15,118178,942 total(indirect: See footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-181,832,5820 total(indirect: See footnote)
    Common Stock (1,832,582 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-18128,2010 total(indirect: See footnote)
    Common Stock (128,201 underlying)
  • Purchase

    Common Stock

    2020-09-18$13.00/sh+15,038$195,49415,038 total(indirect: See footnote)
  • Purchase

    Common Stock

    2020-09-18$13.00/sh+214,962$2,794,506214,962 total(indirect: See footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2020-09-1820,5850 total(indirect: See footnote)
    Common Stock (20,585 underlying)
  • Conversion

    Common Stock

    2020-09-18+1,832,5822,047,544 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+128,201143,239 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+20,585163,824 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+216,1062,715,316 total(indirect: See footnote)
  • Conversion

    Series C Convertible Preferred Stock

    2020-09-18216,1060 total(indirect: See footnote)
    Common Stock (216,106 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-09-1815,1180 total(indirect: See footnote)
    Common Stock (15,118 underlying)
  • Conversion

    Common Stock

    2020-09-18+451,6662,499,210 total(indirect: See footnote)
Transactions
  • Conversion

    Common Stock

    2020-09-18+451,6662,499,210 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+15,118178,942 total(indirect: See footnote)
  • Purchase

    Common Stock

    2020-09-18$13.00/sh+214,962$2,794,506214,962 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+128,201143,239 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+20,585163,824 total(indirect: See footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-181,832,5820 total(indirect: See footnote)
    Common Stock (1,832,582 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-18128,2010 total(indirect: See footnote)
    Common Stock (128,201 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-09-18451,6660 total(indirect: See footnote)
    Common Stock (451,666 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2020-09-1820,5850 total(indirect: See footnote)
    Common Stock (20,585 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2020-09-18216,1060 total(indirect: See footnote)
    Common Stock (216,106 underlying)
  • Purchase

    Common Stock

    2020-09-18$13.00/sh+15,038$195,49415,038 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+1,832,5822,047,544 total(indirect: See footnote)
  • Conversion

    Common Stock

    2020-09-18+216,1062,715,316 total(indirect: See footnote)
  • Conversion

    Series C Convertible Preferred Stock

    2020-09-1815,1180 total(indirect: See footnote)
    Common Stock (15,118 underlying)
Footnotes (5)
  • [F1]The reportable securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of Amir Nashat ("Nashat"), a member of the Issuer's Board of Directors, David Barrett ("Barrett"), Brian Chee ("Chee") and Bryce Youngren ("Youngren" and, together with Nashat, Barrett and Chee, the "Managing Members") are the managing members of PMC VII. Each of the Managing Members, in their respective capacities with respect to PMC VII, may be deemed to have shared voting and dispositive power over the shares held by PP VII.
  • [F2](continued from Footnote 2) Each of PMC VII and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F3]The reportable securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. Each of the Managing Members, in their respective capacities with respect to PMC VII, may be deemed to have shared voting and dispositive power over the shares held by PEF VII.
  • [F4](continued from Footnote 3) Each of PMC VII and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F5]Every 5.1 shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the "Preferred Stock") automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.

Issuer

Metacrine, Inc.

CIK 0001634379

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001678203

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 5:12 PM ET
Size
36.9 KB